Master Hospitality Management, Inc – Trademark Portfolio
Entity Type: 03
Master Hospitality Management, Inc holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 37 (Building & Construction) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include BIO360+. The owner is based in Scottsdale, AZ.
Scottsdale, AZ 85255
Showing of trademarks Trademarks
Trademark Classifications
Master Hospitality Management, Inc's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Master Hospitality Management, Inc have?
Master Hospitality Management, Inc has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned.
What trademark classes does Master Hospitality Management, Inc file in?
Master Hospitality Management, Inc files trademarks across 4 Nice Classification classes. The most active classes are Class 37 (Building & Construction), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 9 (Computers & Electronics). Class 37 covers building construction; repair; installation services.
What are Master Hospitality Management, Inc's most well-known trademarks?
Master Hospitality Management, Inc's registered trademark portfolio includes well-known marks such as BIO360+. These are among 1 currently registered trademark in the portfolio.
What is Master Hospitality Management, Inc's trademark registration success rate?
Master Hospitality Management, Inc has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.